|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01877 JUNSHI BIO
Nominal 
12.900 -1.540 (-10.665%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -19.062% | -20.198% | -7.539% | -26.793% | -17.142% |
| ROAE (%) | -27.370% | -27.328% | -10.412% | -37.728% | -23.576% |
| Return on Capital Employed (%) | -25.673% | -22.089% | -7.954% | -25.553% | -19.489% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 55.589% | 63.792% | 68.739% | 76.642% | 88.300% |
| EBITDA Margin (%) | -146.192% | -163.187% | -7.224% | -94.375% | -92.496% |
| Pre-tax Profit Margin (%) | -165.711% | -184.053% | -14.725% | -104.675% | -98.456% |
| Net Profit Margin (%) | -151.850% | -164.161% | -17.853% | -104.436% | -95.979% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 2.242 X | 4.061 X | 2.892 X | 3.148 X | 3.157 X |
| Quick Ratio (X) | 2.025 X | 3.723 X | 2.652 X | 2.918 X | 2.858 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 35.400% | 22.121% | 24.601% | 27.083% | 32.424% |
| Total Debt / Total Assets (%) | 15.741% | 10.509% | 5.685% | 10.620% | 19.513% |
| Net Debt / Total Assets (%) | -17.510% | -37.176% | -26.029% | -31.635% | -7.938% |
| Total Debt / Shareholders' Funds (%) | 24.942% | 13.909% | 7.891% | 14.565% | 28.876% |
| Long Term Debt / Shareholders' Funds (%) | 16.919% | 9.327% | 7.325% | 9.813% | 25.840% |
| Net Debt / Shareholders' Funds (%) | -27.745% | -49.207% | -36.132% | -43.385% | -11.747% |
| Net Cash / (Debt) ($) | 1.990B | 4.675B | 2.876B | 2.534B | 351.061M |
| Net Cash / (Debt) per share ($) | 2.018 | 4.757 | 3.158 | 2.905 | 0.448 |
| Total Debt / Capital Employed (%) | 20.125% | 12.235% | 6.954% | 13.052% | 22.608% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 310.983 Day | 375.770 Day | 120.105 Day | 256.748 Day | 461.128 Day |
| Receivables Turnover (Day) | 86.534 Day | 191.561 Day | 88.703 Day | 93.915 Day | 74.129 Day |
| Payables Turnover (Day) | 64.236 Day | 59.993 Day | 13.010 Day | 18.917 Day | 27.029 Day |
| Remarks: | Real time quote last updated: 13/11/2024 16:46 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -645,691,000 |
| %Change | -35.199% |
| EPS / (LPS) | RMB -0.660 |
| NBV Per Share (¥) | RMB 6.591 |